Skip to main content
    M

    MAIA Biotechnology Inc. (MAIA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.00
    +0.00 (+0.00%)

    Market Cap: $61.75M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    MAIA Biotechnology Inc. (MAIA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to MAIA Biotechnology are Biomea Fusion (BMEA), Mereo BioPharma Group PLC ADR (MREO) and Actinium Pharmaceuticals (ATNM). By market cap, MAIA Biotechnology ranks 3rd of the 13 companies on this page; Anixa Biosciences (ANIX) is the largest at $91.08M.

    Peer Comparison

    MAIA's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    MAIA Biotechnology (MAIA)$61.75MN/AN/A0.0%N/A0.0%0.00%
    Biomea Fusion Inc (BMEA)$42.31MN/AN/A0.0%N/A0.0%0.00%
    Mereo BioPharma Group PLC ADR (MREO)$49.11MN/A61.3x0.0%-116.6%0.0%0.00%
    Actinium Pharmaceuticals Inc (ATNM)$51.56M4.1x1.3x32.2%N/A-100.0%0.00%
    Mink Therapeutics Inc (INKT)$47.95MN/A236.3x0.0%N/A0.0%0.00%
    Connect Biopharma Holdings Ltd (CNTB)$42.65MN/A13.6x0.0%N/A5667.0%0.00%
    ImageneBio, Inc. (IMA)$43.22MN/A68.5x0.0%N/A0.0%0.00%
    Kazia Therapeutics Ltd ADR (KZIA)$75.65MN/AN/A0.0%N/A312.4%0.00%
    Anixa Biosciences Inc (ANIX)$91.08MN/AN/A0.0%N/A0.0%0.00%
    INmune Bio Inc (INMB)$32.51MN/AN/A0.0%N/A257.1%0.00%
    Oncolytics Biotech Inc (ONCY)$48.51MN/AN/A0.0%N/A0.0%0.00%
    iBio, Inc. Common Stock (IBIO)$51.55MN/A735.4x0.0%N/A975.0%0.00%
    XBiotech Inc (XBIT)$59.76MN/AN/A0.0%N/A-93.3%0.00%
    Peer median$48.81M4.1x64.9x0.0%-116.6%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to MAIA Biotechnology, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Biomea Fusion Inc (BMEA)
    Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat...
    BMEA competitors
    Mereo BioPharma Group PLC ADR (MREO)
    Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases...
    MREO competitors
    Actinium Pharmaceuticals Inc (ATNM)
    Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation...
    ATNM competitors
    Mink Therapeutics Inc (INKT)
    MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic...
    INKT competitors
    Connect Biopharma Holdings Ltd (CNTB)
    Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators...
    CNTB competitors
    ImageneBio, Inc. (IMA)
    ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.
    IMA competitors
    Kazia Therapeutics Ltd ADR (KZIA)
    Kazia Therapeutics Limited, a biotechnology company focused on oncology, develops anticancer drugs. The company is headquartered in Sydney, Australia.
    Anixa Biosciences Inc (ANIX)
    Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases.
    ANIX competitors
    INmune Bio Inc (INMB)
    INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease...
    INMB competitors
    Oncolytics Biotech Inc (ONCY)
    Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer.
    ONCY competitors
    iBio, Inc. Common Stock (IBIO)
    iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States.
    IBIO competitors
    XBiotech Inc (XBIT)
    XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases.
    XBIT competitors

    Frequently Asked Questions About MAIA

    Who are MAIA Biotechnology's main competitors?

    The companies most similar to MAIA Biotechnology include Biomea Fusion (BMEA), Mereo BioPharma Group PLC ADR (MREO), Actinium Pharmaceuticals (ATNM), Mink Therapeutics (INKT) and Connect Biopharma Holdings (CNTB), listed from the closest match.

    Who is MAIA Biotechnology's biggest competitor?

    Anixa Biosciences (ANIX) is the largest of the similar companies at $91.08M; Biomea Fusion (BMEA) is the closest match by business profile, size, sector and industry.

    How does MAIA stock compare with its competitors?

    MAIA's net margin is 0.0% against a peer median of 0.0%.

    Which of MAIA Biotechnology's competitors pays a higher dividend?

    MAIA Biotechnology pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is MAIA Biotechnology bigger than its competitors?

    No. MAIA Biotechnology is 3rd by market cap among the 13 companies on this page; the largest is Anixa Biosciences (ANIX) at $91.08M.